4 resultats
BACKGROUND OF THE INVENTION
This invention relates to benzimidazolone derivatives. These compounds have selective cannabinoid(CB)2 receptor binding activity. The present invention also relates to a pharmaceutical composition, method of treatment and use, comprising the above derivatives for the
BACKGROUND OF THE INVENTION
This invention relates to sulfonyl benzimidazole derivatives. These compounds have selective cannabinoid (CB)2 receptor agonistic activity. The present invention also relates to a pharmaceutical composition, method of treatment and use, comprising the above derivatives
This application is a national phase entry under 35 U.S.C. 371 of international application PCT/EP2008/060564, filed Aug. 12, 2008, which claims priority to PCT/EP2007/058408, filed Aug. 14, 2007, and EP08102047.1, filed Feb. 26, 2008, each of which is hereby incorporated by reference in its
BACKGROUND OF THE INVENTION
This invention relates to tricyclic compounds. These compounds have selective acid pump inhibitory activity. The present invention also relates to a pharmaceutical composition, method of treatment and use, comprising the above derivatives for the treatment of disease